Sentri7 alternatives and competitors for antimicrobial stewardship and antibiogram reporting

Sentri7 competitors compared

Each product is described only from its vendor's public pages, read in September 2026. Where a vendor does not say something publicly, the table says so rather than guessing. Antimicrobe is not affiliated with Wolters Kluwer, Premier, Inovalon, BD or Epic.

TheraDoc, if you want another full platform

Premier's clinical surveillance product, powered by TheraDoc, is the most direct like-for-like swap. Premier's page leads on real-time alerts for antibiotic stewardship, automated NHSN reporting tools, data interfaced with the EHR, and coverage of both acute and post-acute settings. That post-acute coverage is the clearest reason to pick it over Sentri7 for a health system that also runs skilled nursing beds.

The product page does not mention an antibiogram, although a 2021 Premier blog post describes one. If the antibiogram matters to your committee, ask to see it printed, with its de-duplication rule and isolate threshold, rather than on a dashboard.

We cover the other direction of this decision on the TheraDoc competitors and alternatives page.

VigiLanz, if AUR reporting is the urgent problem

VigiLanz is now sold by Inovalon as pharmacy surveillance in its provider cloud, and it won the pharmacy surveillance segment in the 2024 Best in KLAS report before Sentri7 took it in 2026. Inovalon's product page describes near real-time surveillance that works regardless of EHR, pharmacy alerts that appear inside the EHR, NHSN AUR validation, and on-demand and trending antibiogram data.

What makes it a practical alternative for a smaller program is the tiering. Inovalon's 2025 overviews describe a Starter tier limited to AUR reporting through a web interface with no software installs, and a Pro tier with full stewardship, analytics and antibiograms. Its ONC disclosure notes a one-time implementation fee and an annual licensing fee. Neither amount is published.

Which tier includes the antibiogram, and what a Starter customer can do instead of upgrading, is covered on the VigiLanz alternatives and competitors page.

BD HealthSight, if BD already runs your pharmacy

BD HealthSight Clinical Advisor is described as helping streamline house-wide antimicrobial stewardship, using data from the electronic medical record, order entry, laboratory and pathology systems. Its companion, Infection Advisor with MedMined Insights, is a hosted infection surveillance product. BD's page talks about comparing regional and national antibiotic resistance data rather than a facility antibiogram, and its AUR certification appears on a BD page dated January 2022. It is most natural where BD dispensing and pharmacy analytics are already in the building.

What Infection Advisor does that an antibiogram tool does not, and what to check before leaving BD, is on the MedMined and BD HealthSight alternatives page.

Staying inside Epic instead

For an Epic hospital, the alternative to any third-party platform is building the work in the EHR. Epic's certification page lists Bugsy Infection Control as certified for antimicrobial use and resistance reporting, so AUR does not require Sentri7. The stewardship worklists and alerts are a build, though, and published hospital experience from Johns Hopkins in 2021 describes that as needing stewardship physicians, pharmacists and Epic IT staff, with significant time and expertise. Leaving Sentri7 for Epic trades a license for analyst hours.

Our buyer guide to the best antimicrobial stewardship software for community hospitals walks through that trade by EHR, IT time and pharmacist hours.

Keep Sentri7 and move the antibiogram out

Antimicrobe is not a Sentri7 replacement, and presenting it as one would waste your evaluation. It does not fire real-time alerts, does not submit AUR data to NHSN, does not track IV-to-oral conversions or SAAR, and has no drug diversion or dosing module. If your pharmacists work the Sentri7 alert queue every morning, keep it.

What it does is the cumulative antibiogram, done the way CLSI M39 describes. You export finalized susceptibility results from the LIS as a CSV. The builder de-duplicates to the first isolate per patient, marks cells under 30 isolates, applies a named breakpoint set, cuts by unit, source and quarter, counts MDRO phenotypes, and ranks empiric options by local percent susceptible. Every rule is printed on the report, which is what a committee needs and what a dashboard antibiogram often leaves out.

That leaves two realistic patterns. A hospital that renews Sentri7 for alerts and AUR can take the annual antibiogram off the platform and stop rebuilding it by hand. A hospital that is leaving Sentri7 for Epic, where the antibiogram depends on a build, can cover it from the lab export on day one instead of waiting in the analyst queue.

The full list of what is and is not included is on the antimicrobial stewardship software features page, and the hospital antibiogram page shows the finished report.

• Replaces: the hand-built annual antibiogram, unit and source cuts, quarterly trends, the committee pack
• Does not replace: real-time alerts, NHSN AUR submission, SAAR, drug diversion, dosing
• Runs alongside: Sentri7, TheraDoc, VigiLanz, BD HealthSight or Epic, from the same lab data

What to check before you leave Sentri7

The risk in switching is not the new software. It is the gap. These are the items that most often cause one, and each is worth confirming in writing before notice is given.

• AUR continuity: which system submits to NHSN for each month of the CMS reporting period, with no uncovered months
• Intervention history: whether pharmacist interventions and notes export in a usable format, and who keeps them
• Rules: how many custom alert rules you run today, and who rebuilds them in the new system
• Other modules: whether drug diversion, opioid stewardship or dosing also sit on your Sentri7 contract
• Interfaces: the realistic build time for EHR, LIS and eMAR feeds, and how many of your own IT hours it takes
• Contract: the notice period, any auto-renewal date, and the price for keeping one module only

Who should stay on Sentri7

Stay if your stewardship pharmacists work its alerts daily, if it submits your AUR data without trouble, if your diversion program depends on the same platform, or if your pharmacy already buys other Wolters Kluwer products and the contract terms reflect that. A top KLAS-ranked system that is doing its job is a poor thing to replace to fix one report. In that case, keep it and fix the report.